Results 51 to 60 of about 9,259 (270)
TCT-749 The Impact of Race and Gender on Procedural Outcomes After Alcohol Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy [PDF]
, 1997 Digitalitzat per ...
Benton, Stewart M. +8 more
core +2 more sources
Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging, 2022 Alcohol septal ablation (ASA) is an effective treatment for symptomatic hypertrophic obstructive cardiomyopathy (HOCM). Although routine use of myocardial contrast echocardiography (MCE) in guiding ASA has been recommended by guidelines, it has not come ...
Sridhar Lakshmana Sastry +4 more
doaj +1 more source
Fibronectin signals through integrin α5β1 to regulate cardiovascular development in a cell type-specific manner. [PDF]
, 2015 Fibronectin (Fn1) is an evolutionarily conserved extracellular matrix glycoprotein essential for embryonic development. Global deletion of Fn1 leads to mid-gestation lethality from cardiovascular defects.
Astrof, Sophie +7 more
core +2 more sources
КардиоСоматикаBACKGROUND: Hypertrophic cardiomyopathy is a primarily genetically determined myocardial disease characterized by pronounced, often asymmetric, myocardial hypertrophy that results in diastolic dysfunction and left ventricular outflow tract obstruction ...
Mariia S. Nozdriakova +5 more
doaj +1 more source
Myectomy or Alcohol Septal Ablation
Journal of the American College of Cardiology, 2007 Since the development of alcohol septal ablation by Sigwart ([1][1]) and its increasing adoption, the treatment of symptomatic hypertrophic obstructive cardiomyopathy (HOCM) with myectomy versus alcohol septal ablation has generated a passion of debate and disagreement not often seen.
Duke E. Cameron +3 more
openaire +2 more sources
Patient Selection for Alcohol Septal Ablation [PDF]
JACC: Cardiovascular Interventions, 2016 “Age is an issue of mind over matter. If you don’t mind, it doesn’t matter.”—Mark Twain [(1)][1] Septal reduction therapy plays an important role in the treatment of patients with hypertrophic cardiomyopathy (HCM) and symptoms due to a dynamic left ventricular outflow tract ...
Mackram F. Eleid, Rick A. Nishimura
openaire +2 more sources
Septal alcoholization in hypertrophic cardiomyopathy: about 11 cases
The Pan African Medical Journal, 2017 Outcomes of septal alcoholization in hypertrophic obstructive cardiomyopathy are not enough studied in all centers. The purpose of this study was to determine the outcomes of septal alcoholization in hypertrophic obstructive cardiomyopathy in our ...
Yibar Kambire +3 more
doaj +1 more source
Alcohol septal ablation: in which patients and why? [PDF]
Annals of Cardiothoracic Surgery, 2017 At present, surgical septal myectomy is regarded as the "gold standard" treatment for most patients with obstructive hypertrophic cardiomyopathy (HCM) and drug-refractory symptoms. However, the best results are obtained by those surgeons who have extensive experience with this operation at a small number of referral centers.
Jessica Rossi +2 more
openaire +3 more sources
Hypertrophic obstructive cardiomyopathy: alcohol septal ablation [PDF]
European Heart Journal, 2011 Alcohol septal ablation (ASA) was introduced in 1994 as an alternative to septal myectomy for patients with hypertrophic obstructive cardiomyopathy and symptoms refractory to medical therapy. This procedure alleviates symptoms by producing a targeted, limited infarction of the upper interventricular septum, resulting in an increase in left ventricular ...
Fifer, Michael A., Sigwart, Ulrich
openaire +3 more sources
Excess mortality and sex differences in outcome in hypertrophic cardiomyopathy: a European multicentre study [PDF]
, 2019 Background. Contemporary survival studies in hypertrophic cardiomyopathy (HCM) have shown that the prognosis for most individuals with the disease is much better than described previously, but it remains unclear whether HCM conveys an excess mortality ...
Lorenzini, Massimiliano <1983>
core +1 more source